Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 9
1986 6
1987 9
1988 16
1989 6
1990 3
1991 6
1992 7
1993 4
1994 6
1995 12
1996 2
1997 2
1998 2
1999 2
2000 1
2001 1
2002 1
2008 1
2009 1
2011 1
2014 1
2015 1
2018 1
2019 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
First-line onartuzumab plus erlotinib treatment for patients with MET-positive and EGFR mutation-positive non-small-cell lung cancer.
Kishi K, Sakai H, Seto T, Kozuki T, Nishio M, Imamura F, Nokihara H, Satouchi M, Nakagawa S, Tahata T, Nakagawa K. Kishi K, et al. Among authors: tahata t. Cancer Treat Res Commun. 2019;18:100113. doi: 10.1016/j.ctarc.2018.10.004. Epub 2018 Oct 31. Cancer Treat Res Commun. 2019. PMID: 30472556 Free article. Clinical Trial.
Acute pulmonary edema after Blalock-Taussig anastomosis.
Okita Y, Miki S, Kusuhara K, Ueda Y, Tahata T, Yamanaka K, Tamura T. Okita Y, et al. Among authors: tahata t. Ann Thorac Surg. 1992 Apr;53(4):684-5. doi: 10.1016/0003-4975(92)90334-z. Ann Thorac Surg. 1992. PMID: 1554282
Phase I study of the anti-MET antibody onartuzumab in patients with solid tumors and MET-positive lung cancer.
Nishio M, Horiike A, Nokihara H, Horinouchi H, Nakamichi S, Wakui H, Ohyanagi F, Kudo K, Yanagitani N, Takahashi S, Kuboki Y, Yamamoto N, Yamada Y, Abe M, Tahata T, Tamura T. Nishio M, et al. Among authors: tahata t. Invest New Drugs. 2015 Jun;33(3):632-40. doi: 10.1007/s10637-015-0227-5. Epub 2015 Mar 18. Invest New Drugs. 2015. PMID: 25777467 Clinical Trial.
Coronary risk factor profile and prognostic factors for young Japanese patients undergoing coronary revascularization.
Furukawa Y, Ehara N, Taniguchi R, Haruna Y, Ozasa N, Saito N, Doi T, Hoshino K, Tamura T, Shizuta S, Abe M, Toma M, Morimoto T, Teramukai S, Fukushima M, Kita T, Kimura T; CREDO-Kyoto Investigators. Furukawa Y, et al. Circ J. 2009 Aug;73(8):1459-65. doi: 10.1253/circj.cj-08-1083. Epub 2009 Jun 16. Circ J. 2009. PMID: 19531902 Free article.
103 results